Venture Partner at Samsara BioCapital · Joined 2024
View Live Interactive Profile →Alan Eisenberg joined Samsara BioCapital as a Venture Partner in 2024. The firm states he is an executive with over 20 years of experience in biotech and works with portfolio companies on programme and commercialisation strategies with a focus on market access, reimbursement and regulatory matters. He was previously Vice President, Global Public Policy and Government Relations at Alnylam, and before that led government relations for Celgene and spent nearly a decade as Executive Vice President at the Biotechnology Innovation Organization. He served in senior policy making roles on Capitol Hill, where the firm states he was an author of the Average Sales Price methodology used in Medicare Part B reimbursement and a member of teams responsible for Medicare Part D and PDUFA III. Earlier in his career he worked at Ford Motor Company as an economist and finance manager. He holds a Masters in Public Policy from Harvard University, a Masters in Finance from George Washington University and a Bachelors in Science from Union College.